Literature DB >> 19797074

OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.

Tracy F Nicholson1, Kristin M Watts, David A Hunstad.   

Abstract

Type 1 pilus directs bladder epithelial binding and invasion by uropathogenic Escherichia coli (UPEC) in the initial stage of cystitis, but the bacterial determinants of postinvasion events in the pathogenesis of cystitis are largely undetermined. We show here that the UPEC outer membrane protein A (OmpA), a monomeric, major, integral protein component of the bacterial outer membrane, functions as a critical determinant of intracellular virulence for UPEC, promoting persistent infection within bladder epithelium. Using a murine urinary tract infection (UTI) model, we demonstrate that whereas deletion of the UPEC ompA gene did not disrupt initial epithelial binding and invasion by UPEC, it did preclude completion of the intracellular bacterial community (IBC) pathway, accompanied by diminishing bacterial loads in the bladder. This defect in epithelial persistence of the ompA mutant was enhanced in competitive infections with wild-type UPEC. Microscopic examinations revealed that the ompA mutant formed significantly fewer IBCs, and those that were initiated were unable to progress past the early stages of maturation. These defects could be corrected by complementation of ompA. In addition, expression of ompA during wild-type UTI was sharply increased at time points correlated with IBC development and the arrival of host immune effector cells. Our findings establish OmpA as a key UPEC virulence factor that functions after epithelial invasion to facilitate IBC maturation and chronic bacterial persistence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797074      PMCID: PMC2786482          DOI: 10.1128/IAI.00670-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies.

Authors:  Pascale Jeannin; Giovanni Magistrelli; Liliane Goetsch; Jean-Francois Haeuw; Nathalie Thieblemont; Jean-Yves Bonnefoy; Yves Delneste
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

2.  Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.

Authors:  Pascale Jeannin; Giovanni Magistrelli; Nathalie Herbault; Liliane Goetsch; Sylvie Godefroy; Peggy Charbonnier; Alexandra Gonzalez; Yves Delneste
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

3.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

Review 4.  Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Gregory G Anderson; Karen W Dodson; Thomas M Hooton; Scott J Hultgren
Journal:  Trends Microbiol       Date:  2004-09       Impact factor: 17.079

5.  Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.

Authors:  Indira U Mysorekar; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

6.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Outer membrane protein A deficient Escherichia coli activates neutrophils to produce superoxide and shows increased susceptibility to antibacterial peptides.

Authors:  Huamei Fu; Abderr Azzaq Belaaouaj; Claes Dahlgren; Johan Bylund
Journal:  Microbes Infect       Date:  2003-07       Impact factor: 2.700

8.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Sheryl S Justice; Chia Hung; Julie A Theriot; Daniel A Fletcher; Gregory G Anderson; Matthew J Footer; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

9.  Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue.

Authors:  Nemani V Prasadarao; Pramod K Srivastava; Rajyalakshmi S Rudrabhatla; Kwang Sik Kim; Sheng-he Huang; Sunil K Sukumaran
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  34 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

3.  Androgens Enhance Male Urinary Tract Infection Severity in a New Model.

Authors:  Patrick D Olson; Keith A Hruska; David A Hunstad
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

Review 4.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

5.  Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Erik Chorell; Jan M Crowley; Corinne K Cusumano; Scott Campbell; Jeffrey P Henderson; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2012-04-13       Impact factor: 7.446

6.  Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.

Authors:  Jennifer A Loughman; David A Hunstad
Journal:  J Infect Dis       Date:  2012-04-03       Impact factor: 5.226

7.  Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Authors:  Pascale S Guiton; Corinne K Cusumano; Kimberly A Kline; Karen W Dodson; Zhenfu Han; James W Janetka; Jeffrey P Henderson; Michael G Caparon; Scott J Hultgren
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 8.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

9.  Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion.

Authors:  Nathalie Rolhion; Nicolas Barnich; Marie-Agnès Bringer; Anne-Lise Glasser; Julien Ranc; Xavier Hébuterne; Paul Hofman; Arlette Darfeuille-Michaud
Journal:  Gut       Date:  2010-06-29       Impact factor: 23.059

10.  Purification of Intracellular Bacterial Communities during Experimental Urinary Tract Infection Reveals an Abundant and Viable Bacterial Reservoir.

Authors:  Suhanya Duraiswamy; Jacqueline L Y Chee; Siyi Chen; Enjun Yang; Kristin Lees; Swaine L Chen
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.